Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 411

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 411
---
 to be proposed
at any general meeting of the Company; and

(b) shall not
be entitled to receive any dividend or other distribution of out of the profits of the Company.

In the event of a distribution
of assets, the deferred shareholders shall receive the nominal amount paid up on such share after the holder of each ordinary share shall
have received (in cash or specie) the amount paid up or credited as paid up on such ordinary share together with an additional payment
of £100 per share. The Company has the authority to purchase the deferred shares and may require the holder of the deferred shares
to sell them for a price not exceeding 1p for all the deferred shares.

| F-69 |

| 21 | Share capital (continued) |

| Schedule of ordinary and deferred shares |     |                                |     |                        |     |               |     |               |     |         |     |                           |
|                                          |     |                                |     | Ordinary Shares Number |     |  ‘A’ Deferred 
 Shares Number |     |  ‘B’ Deferred 
 Shares Number |     |   Share 
 Price £ |     | Total consideration £’000 |
| At 1 January 2021                        |     |                                |     |              3,153,694 |     |     1,000,001 |     |               |     |         |     |                           |
| 19 February 2021                         |     | Exercise                       
 of warrants                    |     |                 15,340 |     |               |     |               |     |   5.960 |     |                        91 |
| 6 July 2021                              |     | Placing                        |     |              1,754,386 |     |               |     |               |     |   5.700 |     |                    10,000 |
| At 31 December 2021                      |     |                                |     |              4,923,420 |     |     1,000,001 |     |               |     |         |     |                           |
| 22 March 2022                            |     | Exercise of warrants           |     |                      1 |     |               |     |               |     | 200.000 |     |                         – |
| 3 May 2022                               |     | Share issue to SIPP trustee    
 (see note 24)                  |     |                  1,250 |     |               |     |               |     |